MPL S505C enhances driver mutations at W515 in essential thrombocythemia

Affiliations

Leila N. Varghese: Université Catholique de Louvain and de Duve Institute
Gonzalo Carreño-Tarragona: Haematology and Haemotherapy Department, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC
Gabriel Levy: Université Catholique de Louvain and de Duve Institute
Xabier Gutiérrez-López de Ocáriz: Haematology and Haemotherapy Department, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC
Inmaculada Rapado: Haematology and Haemotherapy Department, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC
Joaquín Martínez-López: Haematology and Haemotherapy Department, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC
Rosa Ayala: Haematology and Haemotherapy Department, Hospital Universitario 12 de Octubre, I+12, CNIO, Complutense University, CIBERONC
Stefan N. Constantinescu: Université Catholique de Louvain and de Duve Institute

Abstract

No abstracts available.

ISSN: 2044-5385 (Online)
Publisher: Nature Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://www.nature.com/bcj/index.html